Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
0.8850
-0.0160 (-1.78%)
At close: Jun 24, 2025, 4:00 PM
0.8770
-0.0080 (-0.90%)
Pre-market: Jun 25, 2025, 4:13 AM EDT
Femasys Employees
As of December 31, 2024, Femasys had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees increased by 37 or 108.82% compared to the previous year.
Employees
71
Change (1Y)
37
Growth (1Y)
108.82%
Revenue / Employee
$23,933
Profits / Employee
-$297,380
Market Cap
28.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
FEMY News
- 7 days ago - Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewsWire
- 13 days ago - Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations - GlobeNewsWire
- 26 days ago - Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement - GlobeNewsWire
- 6 weeks ago - Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations - GlobeNewsWire
- 3 months ago - Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain - GlobeNewsWire
- 3 months ago - Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach - GlobeNewsWire